Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/ctr.13991 http://scihub22266oqcxt.onion/10.1111/ctr.13991 32446267!7267091!32446267     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Transplant 2020 ; 34 (7): e13991 Nephropedia Template TP {{tp|p=32446267|t=2020. What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19 |pdf=|usr=}}{{32446267}} gab.com Text What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19 JO: Clin Transplant http://www.kidney.de/pget.php?&tw=1&pmid=32446267 #FOAvip The data on the outcomes of solid organ transplant recipients who have contracted coronavirus disease 2019 (COVID-19) are still emerging. Kidney transplant recipients are commonly prescribed renin-angiotensin-aldosterone system (AAS) inhibitors given the prevalence of hypertension, diabetes, and cardiovascular disease. As the angiotensin-converting enzyme 2 (ACE2) facilitates the entry of coronaviruses into target cells, there have been hypotheses that preexisting use of renin-angiotensin-aldosterone system (RAAS) inhibitors may increase the risk of developing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Given the common use of RAAS inhibitors among solid organ transplant recipients, we sought to review the RAAS cascade, the mechanism of SARS-CoV-2 entry, and pertinent data related to the effect of RAAS inhibitors on ACE2 to guide management of solid organ transplant recipients during the COVID-19 pandemic. At present, there is no clear evidence to support the discontinuation of RAAS inhibitors in solid organ transplant recipients during the COVID-19 pandemic. Twit Text FOAVip What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19 ????Clin Transplant http://www.kidney.de/pget.php?&tw=1&pmid=32446267 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32446267 #FOAvip English Wikipedia <ref>{{Cite pmid|32446267}}</ref> What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19 #MMPMID32446267 Wong SY; Brubaker AL; Wang AX; Taiwo AA; Melcher ML Clin Transplant 2020[Jul]; 34 (7): e13991 PMID32446267show ga The data on the outcomes of solid organ transplant recipients who have contracted coronavirus disease 2019 (COVID-19) are still emerging. Kidney transplant recipients are commonly prescribed renin-angiotensin-aldosterone system (AAS) inhibitors given the prevalence of hypertension, diabetes, and cardiovascular disease. As the angiotensin-converting enzyme 2 (ACE2) facilitates the entry of coronaviruses into target cells, there have been hypotheses that preexisting use of renin-angiotensin-aldosterone system (RAAS) inhibitors may increase the risk of developing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Given the common use of RAAS inhibitors among solid organ transplant recipients, we sought to review the RAAS cascade, the mechanism of SARS-CoV-2 entry, and pertinent data related to the effect of RAAS inhibitors on ACE2 to guide management of solid organ transplant recipients during the COVID-19 pandemic. At present, there is no clear evidence to support the discontinuation of RAAS inhibitors in solid organ transplant recipients during the COVID-19 pandemic. |*Betacoronavirus[MESH] |*Organ Transplantation[MESH] |Angiotensin Receptor Antagonists/*therapeutic use[MESH] |Angiotensin-Converting Enzyme Inhibitors/*therapeutic use[MESH] |COVID-19[MESH] |Cardiovascular Diseases/complications/*therapy[MESH] |Coronavirus Infections/*complications/diagnosis/therapy[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/diagnosis/therapy[MESH] |Renin-Angiotensin System/physiology[MESH]What solid organ transplant healthcare providers should know about re(epmc).pdf DeepDyve Pubget Overpricing